VanEck Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $238M | Buy |
|
|||||
|
2025
Q1 | $223M | Sell |
|
|||||
|
2024
Q4 | $211M | Buy |
|
|||||
|
2024
Q3 | $243M | Buy |
|
|||||
|
2024
Q2 | $218M | Sell |
|
|||||
|
2024
Q1 | $191M | Buy |
|
|||||
|
2023
Q4 | $129M | Buy |
|
|||||
|
2023
Q3 | $113M | Buy |
|
|||||
|
2023
Q2 | $87M | Sell |
|
|||||
|
2023
Q1 | $63.8M | Sell |
|
|||||
|
2022
Q4 | $77.3M | Sell |
|
|||||
|
2022
Q3 | $70.3M | Buy |
|
|||||
|
2022
Q2 | $68.6M | Buy |
|
|||||
|
2022
Q1 | $48.3M | Buy |
|
|||||
|
2021
Q4 | $46.1M | Buy |
|
|||||
|
2021
Q3 | $34.2M | Buy |
|
|||||
|
2021
Q2 | $30.2M | Buy |
|
|||||
|
2021
Q1 | $13.2M | Sell |
|
|||||
|
2020
Q4 | $15.8M | Buy |
|
|||||
|
2020
Q3 | $13.2M | Sell |
|
|||||
|
2020
Q2 | $16.9M | Sell |
|
|||||
|
2020
Q1 | $20.4M | Sell |
|
|||||
|
2019
Q4 | $21.7M | Buy |
|
|||||
|
2019
Q3 | $12.3M | Sell |
|
|||||
|
2019
Q2 | $12.8M | Buy |
|
|||||
|
2019
Q1 | $14.5M | Sell |
|
|||||
|
2018
Q4 | $19.9M | Sell |
|
|||||
|
2018
Q3 | $42.3M | Sell |
|
|||||
|
2018
Q2 | $54.4M | Buy |
|
|||||
|
2018
Q1 | $45.5M | Buy |
|
|||||
|
2017
Q4 | $44.8M | Sell |
|
|||||
|
2017
Q3 | $46.8M | Buy |
|
|||||
|
2017
Q2 | $43.2M | Buy |
|
|||||
|
2017
Q1 | $43.7M | Buy |
|
|||||
|
2016
Q4 | $35.2M | Buy |
|
|||||
|
2016
Q3 | $31.8M | Sell |
|
|||||
|
2016
Q2 | $32M | Buy |
|
|||||
|
2016
Q1 | $11.9M | Sell |
|
|||||
|
2015
Q4 | $16.9M | Buy |
|
|||||
|
2015
Q3 | $15.8M | Sell |
|
|||||
|
2015
Q2 | $17.8M | Sell |
|
|||||
|
2015
Q1 | $15.8M | Buy |
|
|||||
|
2014
Q4 | $14.4M | Sell |
|
|||||
|
2014
Q3 | $17.5M | Buy |
|
|||||
|
2014
Q2 | $15.8M | Buy |
|
|||||
|
2014
Q1 | $14.1M | Sell |
|
|||||
|
2013
Q4 | $38.1M | Buy |
|
|||||
|
2013
Q3 | $10.3M | Sell |
|
|||||
|
2013
Q2 | $10.3M | Buy |
|